» Authors » Hoang M Lai

Hoang M Lai

Explore the profile of Hoang M Lai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 147
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lai H, Pawar R, Wolf D, Aronow W
Am J Ther . 2014 Jun; 23(2):e357-62. PMID: 24897624
Immunosuppression with calcineurin inhibitors has contributed to an increased prevalence of hypertension, diabetes, and hypercholesterolemia in patients receiving liver transplantation. This study evaluated the prevalence of cardiovascular risk factors, their...
2.
Lai H, Aronow W, Mercando A, Kalen P, Desai H, Gandhi K, et al.
Arch Med Sci . 2012 Aug; 8(3):444-8. PMID: 22851998
Introduction: To investigate differences between outpatients with progressive and nonprogressive coronary artery disease (CAD) measured by coronary angiography. Material And Methods: Chart reviews were performed in patients in an outpatient...
3.
Lai H, Aronow W, Mercando A, Kalen P, Desai H, Gandhi K, et al.
Am J Ther . 2012 Jul; 21(2):68-72. PMID: 22820715
This study investigated the effects of medical therapy on incidences of myocardial infarction (MI), percutaneous coronary intervention (PCI), and coronary artery bypass graft surgery (CABG) in an academic outpatient cardiology...
4.
Lai H, Aronow W, Chugh S, Pudasaini B, Goel A, Garrick R
Am J Ther . 2012 Jul; 20(6):607-12. PMID: 22820714
The purpose of this study was to identify risk factors for renal failure requiring hemodialysis and mortality in patients who developed contrast-induced nephropathy (CIN) after cardiac catheterization. Out of 13,742...
5.
Mercando A, Lai H, Aronow W, Kalen P, Desai H, Gandhi K, et al.
Arch Med Sci . 2012 Mar; 8(1):57-62. PMID: 22457676
Introduction: Although atherosclerotic disease cannot be cured, risk of recurrent events can be reduced by application of evidence-based treatment protocols involving aspirin, beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor...
6.
Lai H, Aronow W, Mercando A, Kalen P, Desai H, Gandhi K, et al.
Arch Med Sci . 2012 Mar; 8(1):53-6. PMID: 22457675
Introduction: Statins reduce coronary events in patients with coronary artery disease. Material And Methods: Chart reviews were performed in 305 patients (217 men and 88 women, mean age 74 years)...
7.
Gandhi K, Aronow W, Desai H, Amin H, Lai H, Frishman W, et al.
Arch Med Sci . 2012 Mar; 6(6):900-3. PMID: 22427764
Introduction: The aim of the study was to investigate at long-term follow-up the incidence of appropriate implantable cardioverter-defibrillator (ICD) shocks and of all-cause mortality in patients with ICDs with ischemic...
8.
Lai H, Aronow W, Mercando A, Kalen P, Desai H, Gandhi K, et al.
Med Sci Monit . 2011 Dec; 17(12):CR683-6. PMID: 22129898
Background: Statins reduce coronary events in patients with coronary artery disease. Material/methods: Chart reviews were performed in 305 patients (217 men and 88 women, mean age 74 years) not treated...
9.
Lai H, Holtzman D, Aronow W, DeLuca A, Ahn C, Matayev S, et al.
Clin Cardiol . 2011 Nov; 35(1):61-3. PMID: 22083587
Background: An increasing coronary artery calcium score is associated with a higher likelihood of myocardial ischemia. Hypothesis: The association of the coronary calcium score with myocardial ischemia in different coronary...
10.
Lai H, Aronow W, Kalen P, Adapa S, Patel K, Goel A, et al.
Int J Nephrol Renovasc Dis . 2011 Jun; 2:33-7. PMID: 21694919
The objective was to investigate the incidence of thromboembolic stroke in patients with chronic kidney disease (CKD) and atrial fibrillation (AF) treated with and without warfarin. We investigated the incidence...